Quick Answer
SPRUCE BIOSCIENCES, INC. reported Stockholders Equity of $42.52 million for the year ending 2025.
- SPRUCE BIOSCIENCES, INC. showed an increase of +47.5% in Stockholders Equity from 2024 to 2025.
- This data is from SPRUCE BIOSCIENCES, INC.'s annual report (Form 10-K), filed with the SEC on March 9, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2019: -$21.91 million | Q2 2019: -$25.07 million | Q3 2019: -$27.52 million | Q1 2020: -$35.77 million | Q2 2020: -$42.12 million | Q3 2020: -$51.44 million | Q1 2021: $140.72 million | Q2 2021: $130.11 million | Q3 2021: $119.72 million | Q1 2022: $100.24 million | Q2 2022: $89.12 million | Q3 2022: $78.48 million | Q1 2023: $108.00 million | Q2 2023: $96.56 million | Q3 2023: $85.38 million | Q1 2024: $66.62 million | Q2 2024: $59.17 million | Q3 2024: $51.64 million | Q1 2025: $15.32 million | Q2 2025: $13.18 million | Q3 2025: $5.39 million.
- Over the full 8 years of available data (2018 to 2025), SPRUCE BIOSCIENCES, INC.'s Stockholders Equity has grown by 338.8%.
- Historical annual values: Fiscal year 2025: $42.52 million | Fiscal year 2024: $28.82 million | Fiscal year 2023: $76.51 million | Fiscal year 2022: $68.49 million | Fiscal year 2021: $111.37 million | Fiscal year 2020: $149.43 million | Fiscal year 2019: -$30.64 million | Fiscal year 2018: -$17.80 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: